Nur Ink Innovations Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
NURI
IL0011757288
Specialty Chemicals
Sales 2022 | - | Sales 2023 | - | Capitalization | 53.72M 198M |
---|---|---|---|---|---|
Net income 2022 | -11M -40.61M | Net income 2023 | -12M -44.3M | EV / Sales 2022 | - |
Net cash position 2022 | 17.77M 65.59M | Net cash position 2023 | 7.22M 26.67M | EV / Sales 2023 | - |
P/E ratio 2022 |
-13.6
x | P/E ratio 2023 |
-
| Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 48.32% |
Managers | Title | Age | Since |
---|---|---|---|
Moshe Nur
CEO | Chief Executive Officer | 74 | 18-11-13 |
David Gerbi
DFI | Director of Finance/CFO | 44 | 21-01-25 |
Moshe Nakash
CTO | Chief Tech/Sci/R&D Officer | 60 | 22-03-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 19-09-01 | |
Sarel Ashkenazi
BRD | Director/Board Member | 51 | 21-01-25 |
Moshe Nur
CEO | Chief Executive Officer | 74 | 18-11-13 |
1st Jan change | Capi. | |
---|---|---|
+9.40% | 3.99B | |
+13.87% | 1.92B | |
+23.81% | 1.11B | |
+8.03% | 1.02B | |
+37.78% | 764M | |
+58.52% | 720M | |
-8.11% | 656M | |
+31.44% | 599M | |
+25.41% | 547M |